Hansmann Yves
Curr Probl Dermatol. 2009;37:111-129. doi: 10.1159/000213071. Epub 2009 Apr 8.
Randomized controlled trials have ascertained the efficiency of antibiotics in treating erythema migrans, the hallmark of early stage Lyme borreliosis. Oral amoxicillin and doxycycline are first-line treatment options, though phenoxymethylpenicillin, cefuroxime axetil and azithromycin are alternative second-line options. Treatments for secondary and tertiary Lyme borreliosis are more poorly documented, and antibiotics are not always effective. This is due to the unique pathophysiology of late Lyme borreliosis, which involves not only bacterial infection, but also immunological response. Since there is no completely reliable method of diagnosis, it is difficult to choose the proper treatment and to evaluate treatment efficacy. However, numerous studies have shown that ceftriaxone and doxycycline are the 2 most efficient antibiotics, particularly in Lyme arthritis and in neuroborreliosis. In late Lyme borreliosis, these antibiotics are less efficient, and different treatment schemes with variations in dosage or duration did not produce convincing results.
随机对照试验已确定抗生素在治疗游走性红斑(早期莱姆病疏螺旋体病的标志)方面的有效性。口服阿莫西林和多西环素是一线治疗选择,不过苯氧甲基青霉素、头孢呋辛酯和阿奇霉素是替代性二线选择。关于二期和三期莱姆病疏螺旋体病的治疗,文献记载较少,而且抗生素并非总是有效。这是由于晚期莱姆病疏螺旋体病独特的病理生理学,它不仅涉及细菌感染,还涉及免疫反应。由于没有完全可靠的诊断方法,因此难以选择合适的治疗方法并评估治疗效果。然而,大量研究表明头孢曲松和多西环素是最有效的两种抗生素,特别是在莱姆关节炎和神经莱姆病方面。在晚期莱姆病疏螺旋体病中,这些抗生素的效果较差,不同的剂量或疗程变化的治疗方案并未产生令人信服的结果。